Episode 146: PREMIUM Two potentially practice changing studies
In episode 146, a PREMIUM podcast, Mike and James talk about some timely studies. Mike discusses some interesting results from a study that looked at the simple intervention of taking antihypertensives...
View ArticleEpisode 180: A RELYable ARISTOTELian look at ROCKET science
In episode 180, Mike and James invite Mike Kolber back to go over the three major trials that have compared warfarin to the new oral anticoagulants. We try, with limited success, to put all the science...
View ArticleEpisode 247: How the new anticoagulants compare to warfarin in DVTs and PEs
In episode 247, Mike and James and Mike look at the evidence for the new anticoagulants compared to warfarin in the treatment of DVTs and PEs. At the end we realise the decision between these agents is...
View ArticleEpisode 146: PREMIUM Two potentially practice changing studies
In episode 146, a PREMIUM podcast, Mike and James talk about some timely studies. Mike discusses some interesting results from a study that looked at the simple intervention of taking antihypertensives...
View ArticleEpisode 180: A RELYable ARISTOTELian look at ROCKET science
In episode 180, Mike and James invite Mike Kolber back to go over the three major trials that have compared warfarin to the new oral anticoagulants. We try, with limited success, to put all the science...
View ArticleEpisode 247: How the new anticoagulants compare to warfarin in DVTs and PEs
In episode 247, Mike and James and Mike look at the evidence for the new anticoagulants compared to warfarin in the treatment of DVTs and PEs. At the end we realise the decision between these agents is...
View Article
